635 related articles for article (PubMed ID: 22710578)
1. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study.
Hong SH; Lee EK; Shin JY
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):479-488. PubMed ID: 30848536
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.
Jayatilaka S; Shakov R; Eddi R; Bakaj G; Baddoura WJ; DeBari VA
Ann Clin Lab Sci; 2007; 37(3):241-7. PubMed ID: 17709687
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.
Lowe DO; Mamdani MM; Kopp A; Low DE; Juurlink DN
Clin Infect Dis; 2006 Nov; 43(10):1272-6. PubMed ID: 17051491
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
Kaneria MV; Paul S
J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
10. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
Deshpande A; Pant C; Pasupuleti V; Rolston DD; Jain A; Deshpande N; Thota P; Sferra TJ; Hernandez AV
Clin Gastroenterol Hepatol; 2012 Mar; 10(3):225-33. PubMed ID: 22019794
[TBL] [Abstract][Full Text] [Related]
11. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of suspected Clostridium difficile-associated hospital-acquired diarrhea in hospitalized patients at Siriraj Hospital.
Thipmontree W; Kiratisin P; Manatsathit S; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S207-16. PubMed ID: 21721449
[TBL] [Abstract][Full Text] [Related]
13. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
Choudhry MN; Soran H; Ziglam HM
QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
[TBL] [Abstract][Full Text] [Related]
14. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
[TBL] [Abstract][Full Text] [Related]
16. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
Kim JW; Lee KL; Jeong JB; Kim BG; Shin S; Kim JS; Jung HC; Song IS
World J Gastroenterol; 2010 Jul; 16(28):3573-7. PubMed ID: 20653067
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.
Biswal S
Biomed J; 2014; 37(4):178-83. PubMed ID: 25116712
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D
Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086
[TBL] [Abstract][Full Text] [Related]
20. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients.
Al-Tureihi FI; Hassoun A; Wolf-Klein G; Isenberg H
J Am Med Dir Assoc; 2005; 6(2):105-8. PubMed ID: 15871884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]